Co-Authors
This is a "connection" page, showing publications co-authored by Martin Hoenigl and Juergen Prattes.
Connection Strength
1.413
-
COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges. Intensive Care Med. 2021 11; 47(11):1339-1340.
Score: 0.241
-
Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2021 Aug 26.
Score: 0.241
-
Serum Lateral Flow assay with digital reader for the diagnosis of invasive pulmonary aspergillosis: A two-centre mixed cohort study. Mycoses. 2021 Oct; 64(10):1197-1202.
Score: 0.240
-
Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry. Intensive Care Med. 2021 10; 47(10):1158-1160.
Score: 0.239
-
Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy. J Fungi (Basel). 2021 Jan 27; 7(2).
Score: 0.232
-
Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report. Med Mycol Case Rep. 2021 Mar; 31:2-5.
Score: 0.220